Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
548.40
-7.8 (-1.4%)
BSENSE

Nov 20

BSE+NSE Vol: 1.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
309.07
257.49
326.08
277.77
247.06
203.99
429.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
309.07
257.49
326.08
277.77
247.06
203.99
429.88
Raw Material Cost
63.66
69.85
70.54
66.59
57.30
59.91
80.27
Purchase of Finished goods
16.24
11.29
15.67
20.44
13.65
12.85
10.32
(Increase) / Decrease In Stocks
-6.35
-26.85
-0.40
-21.30
-21.93
-27.65
37.91
Employee Cost
52.31
43.64
47.77
46.78
44.46
37.90
38.97
Power Cost
36.64
34.72
29.76
28.44
28.53
29.48
29.34
Manufacturing Expenses
0.01
0.00
0.00
0.00
-0.01
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
42.18
42.46
44.21
37.83
36.57
30.11
42.66
Total Expenditure (Excl Depreciation)
204.69
175.11
207.55
178.78
158.57
142.59
239.46
Operating Profit (PBDIT) excl Other Income
104.38
82.38
118.53
98.99
88.49
61.40
190.42
Other Income
10.17
12.83
15.35
9.98
13.35
13.68
9.38
Operating Profit (PBDIT)
114.55
95.21
133.88
108.97
101.84
75.08
199.80
Interest
0.03
0.04
0.08
0.08
0.06
0.06
0.10
Exceptional Items
0.00
0.00
0.00
-3.28
0.00
0.00
0.00
Gross Profit (PBDT)
114.52
95.17
133.80
105.61
101.78
75.02
199.70
Depreciation
18.38
18.10
19.54
18.75
18.39
17.78
14.62
Profit Before Tax
95.48
78.34
114.08
86.16
85.68
58.73
183.54
Tax
25.91
20.65
25.61
22.51
22.62
14.67
43.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
70.23
56.42
88.65
64.34
60.77
42.57
141.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
70.23
56.42
88.65
64.34
60.77
42.57
141.94
Share in Profit of Associates
-0.66
1.28
-0.18
-0.70
2.29
1.49
-1.55
Minority Interest
-1.08
-0.83
-0.32
-0.84
-0.52
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
70.65
58.53
88.79
64.48
63.58
44.06
140.39
Equity Capital
10.46
10.46
10.46
10.46
10.46
10.46
10.46
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.75
5.6
8.49
6.16
6.08
4.21
13.42
Diluted Earnings per share
6.65
5.52
8.46
6.08
6.03
4.21
13.42
Operating Profit Margin (Excl OI)
33.77%
31.99%
36.35%
35.64%
35.82%
30.1%
44.3%
Gross Profit Margin
37.05%
36.96%
41.03%
38.02%
41.2%
36.78%
46.45%
PAT Margin
22.51%
22.41%
27.13%
22.91%
25.52%
21.6%
32.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 20.03% vs -21.03% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 20.71% vs -34.08% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 26.71% vs -30.50% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -50.00% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Concord Biotech With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
309.07
940.17
-631.10
-67.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
309.07
940.17
-631.10
-67.13%
Raw Material Cost
63.66
231.49
-167.83
-72.50%
Purchase of Finished goods
16.24
131.75
-115.51
-87.67%
(Increase) / Decrease In Stocks
-6.35
26.83
-33.18
-123.67%
Employee Cost
52.31
122.32
-70.01
-57.24%
Power Cost
36.64
0.00
36.64
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
42.18
213.49
-171.31
-80.24%
Total Expenditure (Excl Depreciation)
204.69
725.88
-521.19
-71.80%
Operating Profit (PBDIT) excl Other Income
104.38
214.29
-109.91
-51.29%
Other Income
10.17
18.15
-7.98
-43.97%
Operating Profit (PBDIT)
114.55
232.44
-117.89
-50.72%
Interest
0.03
6.83
-6.80
-99.56%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
114.52
225.61
-111.09
-49.24%
Depreciation
18.38
32.11
-13.73
-42.76%
Profit Before Tax
95.48
193.50
-98.02
-50.66%
Tax
25.91
49.98
-24.07
-48.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
70.23
143.53
-73.30
-51.07%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
70.23
143.53
-73.30
-51.07%
Share in Profit of Associates
-0.66
0.00
-0.66
Minority Interest
-1.08
2.21
-3.29
-148.87%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
70.65
141.31
-70.66
-50.00%
Equity Capital
10.46
45.32
-34.86
-76.92%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.75
3.12
3.63
116.35%
Diluted Earnings per share
6.65
3.11
3.54
113.83%
Operating Profit Margin (Excl OI)
33.77%
22.79%
0.00
10.98%
Gross Profit Margin
37.05%
24.00%
0.00
13.05%
PAT Margin
22.51%
15.27%
0.00
7.24%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 309.07 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 20.03% vs -21.03% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 25.10% vs -20.35% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 70.65 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 20.71% vs -34.08% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 11.12% vs -33.59% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.38 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 26.71% vs -30.50% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 17.96% vs -35.25% in Sep 2025

Quarterly - Interest
Interest 0.03 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -50.00% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -50.00% vs -40.00% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.77%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025